Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 378
of 19Next
1:

Morphological types of breast cancer in family members and multiple primary tumours: is morphology genetically determined?

Hemminki K, Granström C.

Breast Cancer Res. 2002;4(4):R7. Epub 2002 Apr 18.

PMID: 12100745 [PubMed - indexed for MEDLINE]

2:

Familial breast carcinoma risks by morphology: a nationwide epidemiologic study from Sweden.

Hemminki K, Granström C.

Cancer. 2002 Jun 1;94(11):3063-70.

PMID: 12115398 [PubMed - indexed for MEDLINE]

3:

Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening.

Rawal R, Lorenzo Bermejo J, Hemminki K.

Br J Cancer. 2005 Jan 17;92(1):162-6.

PMID: 15570309 [PubMed - indexed for MEDLINE]

4:

Identification of women at high genetic risk of breast cancer through the National Health Service Breast Screening Programme (NHSBSP).

de Silva D, Gilbert F, Needham G, Deans H, Turnpenny P, Haites N.

J Med Genet. 1995 Nov;32(11):862-6.

PMID: 8592328 [PubMed - indexed for MEDLINE]

5:

Population attributable risks for breast cancer in Swedish women by morphological type.

Granström C, Sundquist J, Hemminki K.

Breast Cancer Res Treat. 2008 Oct;111(3):559-68. Epub 2007 Nov 8.

PMID: 17990099 [PubMed - indexed for MEDLINE]

6:

Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.

Ji J, Hemminki K.

Breast Cancer Res Treat. 2007 Oct;105(2):229-36. Epub 2006 Nov 18.

PMID: 17115107 [PubMed - indexed for MEDLINE]

7:

Second cancers following in situ carcinoma of the breast.

Franceschi S, Levi F, La Vecchia C, Randimbison L, Te VC.

Int J Cancer. 1998 Jul 29;77(3):392-5.

PMID: 9663601 [PubMed - indexed for MEDLINE]

8:

The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ.

Robinson D, Holmberg L, Møller H.

Br J Cancer. 2008 Aug 19;99(4):611-5. Epub 2008 Jul 29.

PMID: 18665169 [PubMed - indexed for MEDLINE]

9:

Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.

Li CI, Malone KE, Saltzman BS, Daling JR.

Cancer. 2006 May 15;106(10):2104-12.

PMID: 16604564 [PubMed - indexed for MEDLINE]

10:

Attributable risks for familial breast cancer by proband status and morphology: a nationwide epidemiologic study from Sweden.

Hemminki K, Granström C, Czene K.

Int J Cancer. 2002 Jul 10;100(2):214-9.

PMID: 12115572 [PubMed - indexed for MEDLINE]

11:

The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry.

Claus EB, Stowe M, Carter D, Holford T.

Breast. 2003 Dec;12(6):451-6. Review.

PMID: 14659121 [PubMed - indexed for MEDLINE]

12:

Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.

Luke C, Priest K, Roder D.

Asian Pac J Cancer Prev. 2006 Jan-Mar;7(1):69-74.

PMID: 16629519 [PubMed - indexed for MEDLINE]

13:

The BARD1 Cys557Ser variant and breast cancer risk in Iceland.

Stacey SN, Sulem P, Johannsson OT, Helgason A, Gudmundsson J, Kostic JP, Kristjansson K, Jonsdottir T, Sigurdsson H, Hrafnkelsson J, Johannsson J, Sveinsson T, Myrdal G, Grimsson HN, Bergthorsson JT, Amundadottir LT, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K.

PLoS Med. 2006 Jul;3(7):e217.

PMID: 16768547 [PubMed - indexed for MEDLINE]

14:

Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation.

Hill-Kayser CE, Harris EE, Hwang WT, Solin LJ.

Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1313-9. Epub 2006 Sep 25.

PMID: 16997501 [PubMed - indexed for MEDLINE]

15:

MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer.

Liberman L, Morris EA, Dershaw DD, Abramson AF, Tan LK.

AJR Am J Roentgenol. 2003 Apr;180(4):901-10.

PMID: 12646427 [PubMed - indexed for MEDLINE]

16:

Bilateral breast cancer.

Gogas J, Markopoulos C, Skandalakis P, Gogas H.

Am Surg. 1993 Nov;59(11):733-5.

PMID: 8239195 [PubMed - indexed for MEDLINE]

17:

Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes.

Buerger H, Otterbach F, Simon R, Schäfer KL, Poremba C, Diallo R, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W.

J Pathol. 1999 Dec;189(4):521-6.

PMID: 10629552 [PubMed - indexed for MEDLINE]

18:

[Her-2 amplification and p185 expression in invasive breast cancer cells in women]

Titi S.

Ann Acad Med Stetin. 2006;52(2):5-12. Polish.

PMID: 17633393 [PubMed - indexed for MEDLINE]

19:

Familial risks in second primary breast cancer based on a family cancer database.

Hemminki K, Vaittinen P.

Eur J Cancer. 1999 Mar;35(3):455-8.

PMID: 10448299 [PubMed - indexed for MEDLINE]

20:

High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma.

Abdel-Fatah TM, Powe DG, Hodi Z, Lee AH, Reis-Filho JS, Ellis IO.

Am J Surg Pathol. 2007 Mar;31(3):417-26.

PMID: 17325484 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 378
of 19Next